TrialBMC cancer2021

Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC.

Katsuhiko Nakatsukasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.